Egan SE - Search Results

1

RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs.

Robinson TJ, Liu JC, Vizeacoumar F, Sun T, Maclean N, Egan SE, Schimmer AD, Datti A, Zacksenhaus E. Robinson TJ, et al. Among authors: egan se. PLoS One. 2013 Nov 12;8(11):e78641. doi: 10.1371/journal.pone.0078641. eCollection 2013. PLoS One. 2013. PMID: 24265703 Free PMC article.

2

Stra13 homodimers repress transcription through class B E-box elements.

St-Pierre B, Flock G, Zacksenhaus E, Egan SE. St-Pierre B, et al. Among authors: egan se. J Biol Chem. 2002 Nov 29;277(48):46544-51. doi: 10.1074/jbc.M111652200. Epub 2002 Sep 23. J Biol Chem. 2002. PMID: 12297495 Free article.

3

Dynamic regulation of the Stra13/Sharp/Dec bHLH repressors in mammary epithelium.

St-Pierre B, Cooper M, Jiang Z, Zacksenhaus E, Egan SE. St-Pierre B, et al. Among authors: egan se. Dev Dyn. 2004 May;230(1):124-30. doi: 10.1002/dvdy.20013. Dev Dyn. 2004. PMID: 15108316 Free article.

4

High expression during neurogenesis but not mammogenesis of a murine homologue of the Deleted in Breast Cancer2/Rhobtb2 tumor suppressor.

St-Pierre B, Jiang Z, Egan SE, Zacksenhaus E. St-Pierre B, et al. Among authors: egan se. Gene Expr Patterns. 2004 Dec;5(2):245-51. doi: 10.1016/j.modgep.2004.07.009. Gene Expr Patterns. 2004. PMID: 15567721

5

Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.

Adams JR, Xu K, Liu JC, Agamez NM, Loch AJ, Wong RG, Wang W, Wright KL, Lane TF, Zacksenhaus E, Egan SE. Adams JR, et al. Among authors: egan se. Cancer Res. 2011 Apr 1;71(7):2706-17. doi: 10.1158/0008-5472.CAN-10-0738. Epub 2011 Feb 15. Cancer Res. 2011. PMID: 21324922

6

RB1 and p53 at the crossroad of EMT and triple-negative breast cancer.

Jiang Z, Jones R, Liu JC, Deng T, Robinson T, Chung PE, Wang S, Herschkowitz JI, Egan SE, Perou CM, Zacksenhaus E. Jiang Z, et al. Among authors: egan se. Cell Cycle. 2011 May 15;10(10):1563-70. doi: 10.4161/cc.10.10.15703. Epub 2011 May 15. Cell Cycle. 2011. PMID: 21502814 Review.

7

Elevated PI3K signaling drives multiple breast cancer subtypes.

Adams JR, Schachter NF, Liu JC, Zacksenhaus E, Egan SE. Adams JR, et al. Among authors: egan se. Oncotarget. 2011 Jun;2(6):435-47. doi: 10.18632/oncotarget.285. Oncotarget. 2011. PMID: 21646685 Free PMC article. Review.

8

Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.

Liu JC, Voisin V, Bader GD, Deng T, Pusztai L, Symmans WF, Esteva FJ, Egan SE, Zacksenhaus E. Liu JC, et al. Among authors: egan se. Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5832-7. doi: 10.1073/pnas.1201105109. Epub 2012 Mar 28. Proc Natl Acad Sci U S A. 2012. PMID: 22460789 Free PMC article.

9

Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer.

Xu K, Usary J, Kousis PC, Prat A, Wang DY, Adams JR, Wang W, Loch AJ, Deng T, Zhao W, Cardiff RD, Yoon K, Gaiano N, Ling V, Beyene J, Zacksenhaus E, Gridley T, Leong WL, Guidos CJ, Perou CM, Egan SE. Xu K, et al. Among authors: egan se. Cancer Cell. 2012 May 15;21(5):626-641. doi: 10.1016/j.ccr.2012.03.041. Cancer Cell. 2012. PMID: 22624713 Free PMC article.

10

A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions.

Liu JC, Egan SE, Zacksenhaus E. Liu JC, et al. Among authors: egan se. Oncotarget. 2013 Aug;4(8):1317-28. doi: 10.18632/oncotarget.1170. Oncotarget. 2013. PMID: 23945331 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters